Revive TherapeuticsAktie

WKN: A2AP4F | Symbol: RVVTF
0,290
 
USD
03.08.20 Nasdaq OTC
-1,53 %
-0,005 USD
Mehr Daten anzeigen
Smartbroker
NewsFlashAnzeige
DURCHBRUCH für Biotech-Aktie! Klinische Studie ist auf dem Weg zur medizinischen Revolution! Investieren Sie in den Marktführer!

Revive Therapeutics Chart

Neuigkeiten zur Revive Therapeutics Ltd Aktie

ZeitTitel
SmartbrokerJetzt auf smartbroker.de - ab 0 € pro Order handeln! Anzeige
03.08.20
Diskussion: Revive Therapeutics Applies to FDA for Orphan Drug Designation for Treatment of Autoimmune Hepatitis
Avatar swoasik schrieb:
Sehr Interessante Ausführung aus Canada ...aber Lest selbst! Bucillamin (N- …
31.07.20
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
31.07.20
Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
30.06.20
Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19
12.06.20
Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison
09.06.20
Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting
03.06.20
Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19
13.05.20
Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives
29.04.20
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program
23.04.20
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
21.04.20
Revive Therapeutics Announces Research Partnership Agreement with the University of Wisconsin-Madison to Evaluate Novel Formulations and Drug Delivery Technology Focused on Psilocybin-Based Pharmaceuticals
17.04.20
Revive Therapeutics Partners with Complete Phytochemical Solutions to Advance Research Initiatives for Psilocybin-Based Pharmaceutical Products
15.04.20
Revive Therapeutics Announces Closing of Second Tranche of Brokered Private Placement
08.04.20
Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases
03.04.20
Revive Therapeutics Announces Filing of FDA Pre-IND Meeting
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Nachrichten aus der Branche Pharmaindustrie

ZeitTitel
03.08.20
ROUNDUP/Aktien New York Schluss: Daten treiben an - Tech-Indizes auf Rekordhoch
03.08.20
vTv Therapeutics Announces 2020 Second Quarter Financial Results and Update
03.08.20
STERIS Announces Financial Results for Fiscal 2021 First Quarter
03.08.20
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03.08.20
Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020
mehr Branchennachrichten »

Aktuelle Beiträge zur Revive Therapeutics Aktie

Aktienkurs Revive Therapeutics A2AP4F |

BörsenplatzNasdaq OTC
Letzter Kurs0,290USD
Performance-1,53 %
Kurszeit03.08.20
Eröffnung0,330USD
Tageshoch0,394USD
Tagestief0,259USD
Vortageskurs0,295USD
Volumen16,71 Mio.Stk.
52-Wochen Hoch0,300USD
52-Wochen Tief0,017USD
Anzahl Trades3.725
Performance 1 Monat+38,65 %
Performance 1 Jahr+317,73 %

Stammdaten zu Revive Therapeutics

NameRevive Therapeutics Ltd
KurznameRevive Therap
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA2AP4F
SymbolRVVTF
BranchePharmaindustrie
LandKanada Kanada
ReferenzwährungCAD
Aktienanzahl72,41 Mio.
Marktkapitalisierung21,00 Mio.USD

Performance Revive Therapeutics Aktie

ZeitKursPerf.
1 Tag0,290USD
-1,53 %
1 Woche0,188USD
+56,73 %
1 Monat0,212USD
+38,65 %
3 Monate0,105USD
+181,01 %
6 Monate0,040USD
+636,25 %
Lfd. Jahr0,040USD
+632,59 %
1 Jahr0,071USD
+317,73 %
3 Jahre0,146USD
+101,30 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameRevive Therapeutics Ltd
StadtToronto, ON
LandKanada Kanada
Webseitewww.revivethera.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Oroco Resource
0,00
 
2.
Enphase Energy
+1,41
3.
Denali Therapeutics
+3,59
4.
Heritage Cannabis Holdings
-0,77
5.
Empower Clinics
+40,45
6.
Vizsla Resources
+7,11
7.
AgraFlora Organics International
-2,91
8.
Portofino Resources
-8,33
9.
World Class Extractions
-14,29
10.
Pharmadrug
-1,82

Handelsinformationen

Handelszeit07:30 - 18:30 Uhr
Liquidister HandelsplatzCSE